Table 1.
Testosterone Based Regimen | ||
Effect | Onset | Maximum |
Skin Oiliness/acne | 1–6 months | 1–2 years |
Facial/body hair growth | 6–12 months | >5 years |
Scalp hair loss | 6–12 months | >5 years |
Increased muscle mass/strength | 6–12 months | 2–5 years |
Fat redistribution | 1–6 months | 2–5 years |
Cessation of menses | 1–6 months | 1–2 years |
Clitoral enlargement | 1–6 months | 1–2 years |
Vaginal atrophy | 1–6 months | 1–2 years |
Deepening of voice | 1–6 months | 1–2 years |
Estrogen and testosterone-lowering based regimens | ||
Effect | Onset | Maximum |
Redistribution of body fat | 3–6 months | 2–5 years |
Decrease in muscle mass and strength | 3–6 months | 1–2 years |
Softening of skin/decreased oiliness | 3–6 months | Unknown |
Decreased sexual desire | 1–3 months | Unknown |
Decreased spontaneous erections | 1–3 months | 3–6 months |
Decreased sperm production | Unknown | 2 years |
Breast growth | 3–6 months | 2–5 years |
Decreased testicular volume | 3–6 months | Variable |
Decreased terminal hair growth | 6–12 months | > 3 years |
Increased scalp hair | Variable | Variable |
Voice changes | None |
Adapted from Hembree et al., 2017.